pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol CHD9   
Synonyms AD013, CHD-9, CReMM, KISH2, PRIC320
Description chromodomain helicase DNA binding protein 9
Transcript NM_025134   
Expression
Putative miRNA Targets on CHD9
3'UTR of CHD9
(miRNA target sites are highlighted)
>CHD9|NM_025134|3'UTR
   1 TTCCCAGACTCTGCACTTAAAATATGAACTGATTTTGGATTTTTTCTTTAATAATTAATTGTAAATACCCCAGTGTTGAG
  81 TGCATCAATAACTTACTGACCGAACATTTCAGTTATTTGTTTAGAAGTGCAAACTGCTTTCAGAGACTTTTTGCATGTAA
 161 TATTTCTTAAGATTCATAAGTTTCTGAACTCGTATGTACTATCAAATACATAAAGGTGTAAAATTACAACAAAAGGCATT
 241 ATAATTTTGTTGGGGGTTAATTTTATGAAAATTATGCTCAATAAGAGTTGTATATTTAATATATTTGCAGTGAACACAGA
 321 ATACTTTATGCATATTACTGATTTAATTTGAATATAGTTTTACAGCCTCCTTGACACCTATAATTTACAGATCAAAACTC
 401 AGCAATAATTTGGGCAGCTAATGAATGTCATGAAAGCTGTAGAATCTACATCACCATCCATTGCTTTAATTACATGAAAA
 481 TGCTCTAGTGTTGTGATGCACTGCTGATGTTTCCAATTCAGGTACAAGTATGTTTTAAAGAAGAAATAAGTTTCCCAATC
 561 AGCCAATTTAACTGGCTACCTGTTACCTCAGCTGAGTTAGTTTAGGAAGTTTACATTCGTTTCTAATTCTATACTTGTTT
 641 TCAGGGGTTTTTTAAACACATCCTATATATCATGTCAATCTGGCAAGAAATATGACTTGCTTTTTGCTGAGCTTAATTCA
 721 GATATCAGTAAAATTAAGTCATAAAATAATCATGTGTCATGTGACTTTGGCACCCTATAGACATACTTAGTTTTAACTTT
 801 TCAAAGTTTGGCCTCCTATTAGAAATAATCATGTCTCAGATGAGTAATGTCTGTTTCCAGGGTTCAGAAAAGGCAAACTC
 881 ATGAAATGCCACTGAAAAGAACTTTCAACACAGCATACTTCATGTAAAAGAAATTGTTTGTTTGCTTTCTTTGTGTAGAT
 961 TTCTATTTGTGTTTTATGTCATGGAAATATTCCAGAATTAACAGATAATAGTGGTAAAGTAATATGCAGATAGTCTAAAT
1041 TCATTTTGAGTTTCTAGGTGTAAGCAGACTAAATGTTGCCCAGAATCAGTGTTGGGTTATCAGTTTATATTAAATATACT
1121 GAGTTGCCCGTTTTGAAAATGCACTTTGAATAATCTCAAAAAGATGTACAAGTTATACCTGTAAACCACAAAAGTGAAGC
1201 CTGAGGCTTCTGTTCAATTTCATAGACTCCTTTACCATGTAAAATTTGTCTGATATTTGATTTGTGATACAATTTCTCCT
1281 GCTAAAGCTGCTATTATTCTGACAAGGTAGAGGTCCAGGTTCACCTTTATATATATTTAAAACAATTAGTACTGAATTGG
1361 ACATAAAAATATTGACATTCTAAGGAGAGATATATGTTAGCATTTTTCTGGTACTCAAATAAGTTAGTAGTAAAGTCTGC
1441 AAGGGCATAAATTTAGGGGGAAAAAGTGTCCCAGTTCTCTCCTACAGAAAAAATACTTTCAGTATGTTTTGATAAAACTG
1521 TTGCTTTGTCATGAGTTAGTCAATTGTATCAGGTTTTCCAAGACCTTTACCAGTAAATTATGTTTCTGTATGTAAAATAA
1601 CCCCTTATTAGAGAGACAGTGTTATATGTATTTACAAAATTATATAAGTTCCATTGGGATTGTATTGATTTTGTATTTTC
1681 CCAAAATAGTACTTTGAATTGATAGTCCTTTATGCAATGTCTTAGCAATAGTCTCTATAATGCCCATCCAGGAGAAGTGG
1761 GTAGTAATTCTTCATCATGAAAATGATATATTACATATTTAGTATCTTCCCTTTGCAGTATTGCACTTTTGTTTAACTAG
1841 AATACACCTATGAGATAGCCAAAGTTTCAAACACAGTTATCTTAGTTTACCGGTGGAGTATTTCAACACCAACCACATTT
1921 CCCTTCCTCCCTCTAATTCTACCCACATGATCTTTATTCCTTCCTTTCGCCAATTAAAAAAAAAAAAAAGGAAAAAAAAT
2001 CTGTAGATCTTGTCACTAAAATCTAATTTATATCAAATTTATGAGAGAAAGTATTTTCCTAATTATGGTCAAATAAATTT
2081 GGTTAACATCCTAGTGATTCTCTTTCTATATAATAAGGCAATTACAGTTTTCAAAGCATTAAGTCTAACATAACTTTAAA
2161 CATTCTCTTAGGTTTCAAGACACTTCTATTTAATATTCATTGGGGAAAAGTTGTCCAGCTATCAGCTAAGAAAACACATG
2241 CAAATATGGTTGTGTAAAGTTAAGGGTTATAAGGAAAAAAAAATCAGTAGAATTACATAATACTAAAGTTGCAGTTGAAA
2321 GAATATCCAAGTATGTGTTGGTAGTTACTAAAAGAATTATAGCTGTTATTGCCTTGTATTTATAGCCCTTGTTTCAGGTT
2401 TTATGATTCAAGTCTTAGTCCAATCTTTCTTTTGGACATTTGCAATATTTACCAGTTGTGTTTTGTGTAGTCTGAATTTG
2481 CTTTCTGTAGTTGAGCAAACGTCTTAAAAAGTCATTTGTAATTTATTAAATTACTTTCTATGATGTTCTATAGAGCAAAT
2561 GGAAGTTTAATTATTTTTTATTAAACATATTCTTTGACTACCCATGAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucGGCGACA-GUGUGCGUGuc 5'
              |||:| |  | |:||||  
Target 5' ttgcCCGTTTTGAAAATGCACtt 3'
1124 - 1146 118.00 -12.20
2
miRNA  3' agucGGCGA-CAGUGUGCGUGUc 5'
              || ||  |: :|| |||| 
Target 5' cctcCCTCTAATTCTACCCACAt 3'
1926 - 1948 118.00 -5.60
3
miRNA  3' agUCGGCGACAGUGUGCGUGuc 5'
            || :|:|||   |:||||  
Target 5' ctAG-TGTTGT--GATGCACtg 3'
485 - 503 115.00 -13.30
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN17215231 27 COSMIC
COSN30533050 45 COSMIC
COSN31546879 167 COSMIC
COSN6086596 272 COSMIC
COSN31566474 359 COSMIC
COSN31589333 424 COSMIC
COSN20229761 483 COSMIC
COSN31519196 569 COSMIC
COSN6086597 714 COSMIC
COSN31515183 752 COSMIC
COSN31539525 1015 COSMIC
COSN31523332 1052 COSMIC
COSN5835225 1451 COSMIC
COSN31563212 1519 COSMIC
COSN31482951 1551 COSMIC
COSN29462913 1659 COSMIC
COSN26562664 1663 COSMIC
COSN31584760 1687 COSMIC
COSN31482896 1736 COSMIC
COSN31535746 1788 COSMIC
COSN20112883 1875 COSMIC
COSN20112885 1990 COSMIC
COSN31520593 1996 COSMIC
COSN31515485 2002 COSMIC
COSN31579001 2050 COSMIC
COSN30538660 2059 COSMIC
COSN31541020 2060 COSMIC
COSN18983081 2154 COSMIC
COSN31602576 2284 COSMIC
COSN31513255 2304 COSMIC
COSN7260289 2475 COSMIC
COSN26268326 2511 COSMIC
COSN26266926 2514 COSMIC
COSN26602262 2571 COSMIC
COSN28798383 2593 COSMIC
COSN31515609 2593 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs970481539 5 dbSNP
rs1452780165 8 dbSNP
rs778257749 10 dbSNP
rs1416123704 14 dbSNP
rs980304309 15 dbSNP
rs747574464 17 dbSNP
rs757775970 19 dbSNP
rs1384335457 22 dbSNP
rs1226244462 23 dbSNP
rs1308964970 26 dbSNP
rs201410095 28 dbSNP
rs1397763253 40 dbSNP
rs974039999 40 dbSNP
rs748773116 47 dbSNP
rs1283822428 49 dbSNP
rs553697280 50 dbSNP
rs1028428690 76 dbSNP
rs147508306 83 dbSNP
rs560478942 84 dbSNP
rs1446621603 85 dbSNP
rs577320612 89 dbSNP
rs1178029138 98 dbSNP
rs1473757643 102 dbSNP
rs1053258291 103 dbSNP
rs1209177075 129 dbSNP
rs1197403312 133 dbSNP
rs1353950996 134 dbSNP
rs546261907 135 dbSNP
rs562748910 147 dbSNP
rs986874964 149 dbSNP
rs1448294181 156 dbSNP
rs1216868276 172 dbSNP
rs531666075 177 dbSNP
rs769382413 187 dbSNP
rs945152254 188 dbSNP
rs1440820879 195 dbSNP
rs1040544152 197 dbSNP
rs1331425958 200 dbSNP
rs1191895056 204 dbSNP
rs1385504095 217 dbSNP
rs575247018 219 dbSNP
rs1164568584 234 dbSNP
rs925188315 238 dbSNP
rs1378634134 239 dbSNP
rs936345210 241 dbSNP
rs996271546 250 dbSNP
rs1233423717 252 dbSNP
rs548046691 254 dbSNP
rs1449746749 264 dbSNP
rs1163259305 266 dbSNP
rs1222867314 267 dbSNP
rs1361230460 275 dbSNP
rs1283435034 277 dbSNP
rs1222750121 281 dbSNP
rs1411706022 286 dbSNP
rs1421652994 287 dbSNP
rs887733224 298 dbSNP
rs1298999857 308 dbSNP
rs1360084144 309 dbSNP
rs1280741665 314 dbSNP
rs762964130 316 dbSNP
rs894783770 318 dbSNP
rs1314419559 322 dbSNP
rs1340845900 324 dbSNP
rs949177143 325 dbSNP
rs1243970957 326 dbSNP
rs1282414941 332 dbSNP
rs561940975 337 dbSNP
rs1240193199 343 dbSNP
rs1014731303 355 dbSNP
rs1284713601 356 dbSNP
rs907370367 357 dbSNP
rs1410283386 359 dbSNP
rs1212585905 367 dbSNP
rs1258701048 369 dbSNP
rs1479417884 371 dbSNP
rs896323696 381 dbSNP
rs542518742 400 dbSNP
rs1199966620 403 dbSNP
rs1490770763 416 dbSNP
rs1187438755 430 dbSNP
rs1214662931 431 dbSNP
rs1004328636 454 dbSNP
rs1236278093 465 dbSNP
rs1285756348 466 dbSNP
rs1442116406 469 dbSNP
rs1198176402 472 dbSNP
rs1015835435 475 dbSNP
rs898731333 486 dbSNP
rs758339417 490 dbSNP
rs1338870678 492 dbSNP
rs547096198 497 dbSNP
rs1379777308 515 dbSNP
rs1024834648 523 dbSNP
rs1431787879 529 dbSNP
rs995495263 531 dbSNP
rs74017183 532 dbSNP
rs1469351386 544 dbSNP
rs980109501 558 dbSNP
rs1033224061 559 dbSNP
rs1177044297 561 dbSNP
rs1481350559 562 dbSNP
rs774356848 567 dbSNP
rs987292119 569 dbSNP
rs1185651785 570 dbSNP
rs1475547357 572 dbSNP
rs539042050 573 dbSNP
rs966573517 579 dbSNP
rs1460456172 596 dbSNP
rs1395289805 606 dbSNP
rs549395492 619 dbSNP
rs191540547 620 dbSNP
rs913375471 626 dbSNP
rs1272745980 635 dbSNP
rs1307812253 654 dbSNP
rs990730511 655 dbSNP
rs1364421522 656 dbSNP
rs944891838 657 dbSNP
rs1452069255 664 dbSNP
rs1236028798 666 dbSNP
rs1256279661 668 dbSNP
rs538548183 672 dbSNP
rs975840989 673 dbSNP
rs921711070 674 dbSNP
rs1200202003 675 dbSNP
rs1276971176 676 dbSNP
rs1046603581 679 dbSNP
rs1181349523 713 dbSNP
rs1243256678 723 dbSNP
rs554839254 723 dbSNP
rs16952172 724 dbSNP
rs1037147359 726 dbSNP
rs898638268 728 dbSNP
rs1205710049 736 dbSNP
rs1218971381 752 dbSNP
rs1289981753 776 dbSNP
rs16945071 778 dbSNP
rs1049970377 786 dbSNP
rs1317267441 793 dbSNP
rs1437965541 797 dbSNP
rs1201249014 798 dbSNP
rs554299502 804 dbSNP
rs1465751610 810 dbSNP
rs1170535482 826 dbSNP
rs1402203961 829 dbSNP
rs1356086976 834 dbSNP
rs1161400457 836 dbSNP
rs1423612651 838 dbSNP
rs1385410582 843 dbSNP
rs1164996902 848 dbSNP
rs1416786870 849 dbSNP
rs1008227020 851 dbSNP
rs1466074341 852 dbSNP
rs575816692 858 dbSNP
rs1267216497 862 dbSNP
rs1222134415 875 dbSNP
rs546202794 880 dbSNP
rs1294206937 882 dbSNP
rs1237031527 890 dbSNP
rs1316393526 892 dbSNP
rs1307738022 896 dbSNP
rs896302580 898 dbSNP
rs879612713 900 dbSNP
rs1301081218 901 dbSNP
rs1404096772 907 dbSNP
rs1013866553 922 dbSNP
rs1024388010 932 dbSNP
rs1388054322 934 dbSNP
rs562886214 936 dbSNP
rs1451112586 939 dbSNP
rs1362740392 945 dbSNP
rs966772871 955 dbSNP
rs576228319 957 dbSNP
rs545565392 962 dbSNP
rs1230621669 982 dbSNP
rs1199228211 1000 dbSNP
rs957820554 1005 dbSNP
rs1480947910 1026 dbSNP
rs1032942300 1028 dbSNP
rs957383751 1030 dbSNP
rs1261581881 1047 dbSNP
rs1203638269 1056 dbSNP
rs1485644389 1077 dbSNP
rs1261394734 1087 dbSNP
rs989003216 1092 dbSNP
rs1020982587 1095 dbSNP
rs1331213642 1100 dbSNP
rs1281295096 1107 dbSNP
rs966228446 1112 dbSNP
rs1345936965 1115 dbSNP
rs1199804913 1117 dbSNP
rs976694674 1120 dbSNP
rs542107196 1130 dbSNP
rs931684791 1131 dbSNP
rs1211672542 1132 dbSNP
rs1268164446 1147 dbSNP
rs916491677 1151 dbSNP
rs1454886680 1154 dbSNP
rs1176313716 1159 dbSNP
rs544446899 1166 dbSNP
rs1247095348 1180 dbSNP
rs1431948000 1182 dbSNP
rs1191402835 1185 dbSNP
rs1428158570 1188 dbSNP
rs970837138 1192 dbSNP
rs981780830 1214 dbSNP
rs561688684 1218 dbSNP
rs940457308 1226 dbSNP
rs1202991923 1227 dbSNP
rs1197110269 1228 dbSNP
rs1257553401 1231 dbSNP
rs1037388897 1238 dbSNP
rs1425492180 1240 dbSNP
rs1478054717 1248 dbSNP
rs920096254 1251 dbSNP
rs140229567 1256 dbSNP
rs1295804324 1257 dbSNP
rs984551075 1265 dbSNP
rs908856038 1268 dbSNP
rs1050470400 1269 dbSNP
rs1470593280 1273 dbSNP
rs547234882 1284 dbSNP
rs1166579513 1301 dbSNP
rs1036269332 1309 dbSNP
rs896428362 1310 dbSNP
rs1041080204 1316 dbSNP
rs1279760714 1325 dbSNP
rs759008878 1326 dbSNP
rs563819249 1332 dbSNP
rs1184222397 1352 dbSNP
rs999614582 1354 dbSNP
rs1219675511 1361 dbSNP
rs1277998002 1375 dbSNP
rs563866683 1376 dbSNP
rs752169918 1387 dbSNP
rs957893565 1390 dbSNP
rs1230204943 1391 dbSNP
rs1313757356 1396 dbSNP
rs1452713886 1407 dbSNP
rs1342852933 1415 dbSNP
rs571040223 1417 dbSNP
rs905044145 1419 dbSNP
rs1488232011 1426 dbSNP
rs1012076343 1436 dbSNP
rs1208268817 1439 dbSNP
rs1265670151 1440 dbSNP
rs532899927 1448 dbSNP
rs549334577 1451 dbSNP
rs368553747 1461 dbSNP
rs907564817 1462 dbSNP
rs1370168090 1463 dbSNP
rs183364552 1466 dbSNP
rs16945073 1467 dbSNP
rs1020531577 1471 dbSNP
rs1206961727 1478 dbSNP
rs1489755159 1493 dbSNP
rs756892494 1495 dbSNP
rs1290575888 1497 dbSNP
rs1299616272 1498 dbSNP
rs1246129373 1499 dbSNP
rs1357824049 1499 dbSNP
rs1277216782 1500 dbSNP
rs548873245 1505 dbSNP
rs966656170 1508 dbSNP
rs997785340 1511 dbSNP
rs1049908822 1512 dbSNP
rs79157685 1513 dbSNP
rs1297900425 1514 dbSNP
rs1407242381 1524 dbSNP
rs911351910 1531 dbSNP
rs1158003794 1534 dbSNP
rs780783567 1544 dbSNP
rs1398293615 1547 dbSNP
rs984521682 1552 dbSNP
rs1184160382 1562 dbSNP
rs1479317115 1569 dbSNP
rs1314128440 1581 dbSNP
rs1267796003 1582 dbSNP
rs1222799473 1583 dbSNP
rs1452907288 1589 dbSNP
rs1189220477 1601 dbSNP
rs1321167973 1602 dbSNP
rs908990816 1603 dbSNP
rs1281542566 1604 dbSNP
rs1204019814 1606 dbSNP
rs1243825557 1610 dbSNP
rs1041281182 1617 dbSNP
rs961699544 1617 dbSNP
rs534390527 1625 dbSNP
rs972181304 1626 dbSNP
rs1354616766 1628 dbSNP
rs1438888534 1636 dbSNP
rs902526432 1643 dbSNP
rs935313227 1644 dbSNP
rs917596062 1645 dbSNP
rs893870282 1649 dbSNP
rs1012521381 1651 dbSNP
rs1468123331 1653 dbSNP
rs1428376092 1655 dbSNP
rs1191493798 1656 dbSNP
rs554440347 1658 dbSNP
rs1023479529 1668 dbSNP
rs906334535 1674 dbSNP
rs949295404 1684 dbSNP
rs1014760465 1688 dbSNP
rs1045003395 1696 dbSNP
rs1202356569 1699 dbSNP
rs1323372843 1703 dbSNP
rs961720374 1707 dbSNP
rs570922562 1718 dbSNP
rs539961268 1728 dbSNP
rs539884551 1729 dbSNP
rs1431639980 1736 dbSNP
rs936535794 1740 dbSNP
rs986262077 1741 dbSNP
rs1450373536 1746 dbSNP
rs1405247343 1755 dbSNP
rs374282150 1781 dbSNP
rs1176606912 1791 dbSNP
rs911399936 1796 dbSNP
rs893259275 1799 dbSNP
rs944170583 1805 dbSNP
rs977038064 1808 dbSNP
rs1449652867 1821 dbSNP
rs1010323627 1851 dbSNP
rs576391898 1854 dbSNP
rs140529644 1871 dbSNP
rs71143979 1871 dbSNP
rs765905699 1873 dbSNP
rs1238555241 1874 dbSNP
rs76939114 1875 dbSNP
rs60331838 1876 dbSNP
rs1306106097 1892 dbSNP
rs901855635 1893 dbSNP
rs998152628 1896 dbSNP
rs1422017342 1907 dbSNP
rs192308390 1918 dbSNP
rs1313081177 1934 dbSNP
rs1245330263 1941 dbSNP
rs1381996259 1960 dbSNP
rs1303336130 1967 dbSNP
rs1159880763 1969 dbSNP
rs1380391175 1970 dbSNP
rs1418712809 1971 dbSNP
rs1156520805 1972 dbSNP
rs1343783506 1975 dbSNP
rs1053772105 1976 dbSNP
rs1327858119 1976 dbSNP
rs1430014190 1976 dbSNP
rs57955308 1976 dbSNP
rs796783353 1976 dbSNP
rs1415218714 1979 dbSNP
rs1184135293 1985 dbSNP
rs893768578 1990 dbSNP
rs1232669964 1991 dbSNP
rs1045516141 1992 dbSNP
rs948178733 1992 dbSNP
rs1289822717 1997 dbSNP
rs755744225 2003 dbSNP
rs1360280826 2007 dbSNP
rs1029273328 2010 dbSNP
rs1451118071 2013 dbSNP
rs1314888622 2024 dbSNP
rs1229962772 2033 dbSNP
rs1371015083 2038 dbSNP
rs1278801811 2041 dbSNP
rs1311464355 2042 dbSNP
rs1377825109 2043 dbSNP
rs1300884086 2048 dbSNP
rs953514713 2052 dbSNP
rs1006429129 2070 dbSNP
rs1016020124 2076 dbSNP
rs961754060 2082 dbSNP
rs1166207121 2085 dbSNP
rs971850231 2094 dbSNP
rs1357998190 2097 dbSNP
rs1407886115 2103 dbSNP
rs144371676 2113 dbSNP
rs897734267 2123 dbSNP
rs1267149953 2124 dbSNP
rs183275747 2135 dbSNP
rs1313705859 2138 dbSNP
rs1267314392 2142 dbSNP
rs994684469 2147 dbSNP
rs1315129632 2153 dbSNP
rs769131772 2157 dbSNP
rs772786390 2159 dbSNP
rs970439596 2165 dbSNP
rs981081757 2183 dbSNP
rs1267397318 2187 dbSNP
rs926575114 2191 dbSNP
rs1255215643 2201 dbSNP
rs936503050 2204 dbSNP
rs985908272 2205 dbSNP
rs1403960711 2210 dbSNP
rs1367800868 2214 dbSNP
rs1294843541 2224 dbSNP
rs1238238694 2226 dbSNP
rs1450953980 2231 dbSNP
rs1345168685 2236 dbSNP
rs1160580771 2242 dbSNP
rs563957514 2245 dbSNP
rs1427639707 2251 dbSNP
rs74946402 2255 dbSNP
rs186531692 2260 dbSNP
rs946092810 2265 dbSNP
rs770947442 2266 dbSNP
rs901823452 2269 dbSNP
rs1414708552 2271 dbSNP
rs1268803675 2273 dbSNP
rs1331048474 2275 dbSNP
rs924215895 2275 dbSNP
rs1177173364 2276 dbSNP
rs933366315 2280 dbSNP
rs1358956546 2284 dbSNP
rs774254356 2287 dbSNP
rs532838514 2290 dbSNP
rs1006483188 2295 dbSNP
rs1380120439 2309 dbSNP
rs1363866963 2314 dbSNP
rs117481636 2317 dbSNP
rs1401098914 2319 dbSNP
rs1446187478 2327 dbSNP
rs898008213 2332 dbSNP
rs1176239397 2343 dbSNP
rs993631347 2351 dbSNP
rs1369941280 2358 dbSNP
rs1220047891 2359 dbSNP
rs368949946 2361 dbSNP
rs778891324 2373 dbSNP
rs1168638256 2377 dbSNP
rs1428101083 2387 dbSNP
rs1024752937 2389 dbSNP
rs1190529812 2407 dbSNP
rs772010767 2424 dbSNP
rs1045185400 2429 dbSNP
rs928035899 2433 dbSNP
rs1321229034 2443 dbSNP
rs1199708922 2446 dbSNP
rs970789891 2450 dbSNP
rs1200429723 2451 dbSNP
rs1036166843 2456 dbSNP
rs897640804 2457 dbSNP
rs1340943302 2458 dbSNP
rs980499105 2459 dbSNP
rs776935976 2475 dbSNP
rs1229964886 2481 dbSNP
rs1381277931 2501 dbSNP
rs1258674279 2510 dbSNP
rs957915473 2512 dbSNP
rs1404843036 2535 dbSNP
rs1296743408 2540 dbSNP
rs1461684672 2541 dbSNP
rs1391005366 2544 dbSNP
rs1170639495 2548 dbSNP
rs1049418305 2550 dbSNP
rs888823964 2551 dbSNP
rs1186787900 2567 dbSNP
rs1007637307 2569 dbSNP
rs762098762 2572 dbSNP
rs1193840342 2588 dbSNP
rs563098234 2599 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293 , HUVEC , MCF7
Location of target site CDS, 3'UTR
Tools used in this research DIANA-microT , EIMMO , miRanda , miRBase Target Database , PicTar , TargetScan
Article - Fasanaro P; Greco S; Lorenzi M; Pescatori et al.
- The Journal of biological chemistry, 2009
miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3'-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5'-UTR, in line with recent data extending miRNA targeting beyond the "classic" 3'-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.
LinkOut: [PMID: 19826008]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
BLCA -0.631 0 -0.591 0 18 Click to see details
THCA 0.286 0.01 0.306 0.01 59 Click to see details
UCEC 0.47 0.02 0.505 0.01 19 Click to see details
COAD -0.714 0.02 -0.833 0.01 8 Click to see details
STAD -0.303 0.05 -0.332 0.03 32 Click to see details
KIRC -0.189 0.06 -0.118 0.17 68 Click to see details
PRAD -0.218 0.06 -0.212 0.07 50 Click to see details
KIRP 0.245 0.09 0.238 0.09 32 Click to see details
ESCA 0.366 0.13 0.209 0.27 11 Click to see details
HNSC -0.156 0.16 -0.176 0.13 42 Click to see details
PCPG 0.83 0.19 1.000 0.5 3 Click to see details
KICH -0.145 0.24 -0.138 0.26 25 Click to see details
LUSC -0.09 0.3 -0.185 0.13 38 Click to see details
CESC -0.59 0.3 -1.000 0.5 3 Click to see details
LUAD 0.153 0.32 -0.133 0.34 12 Click to see details
LIHC 0.06 0.34 0.056 0.35 49 Click to see details
CHOL 0.122 0.38 0.067 0.43 9 Click to see details
PAAD 0.244 0.38 -0.400 0.3 4 Click to see details
BRCA 0.025 0.41 0.036 0.37 84 Click to see details
BRCA 0.025 0.41 0.036 0.37 84 Click to see details
BRCA 0.025 0.41 0.036 0.37 84 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission